GCS-100 in Combination with R-ICE in Relapsed or Refractory DLBCL

• Research type

  Research Study

• Full title

  A Phase 2 Study of GCS-100 in Combination with Chemo-immunotherapy in Relapsed or Refractory Diffuse Large B-Cell Lymphoma. Protocol Number: PR-CS011

• Contact name

  Rebecca Auer

• Contact email

  r.l.auer@qmul.ac.uk

• Sponsor organisation

  Prospect Therapeutics, Inc.

• Eudract number

  2008-004087-40

• ISRCTN Number

  ISRCTN66315383

• Clinicaltrials.gov Identifier

  NCT

• REC name

  London - Central Research Ethics Committee

• REC reference

  08/H0718/57

• Date of REC Opinion

  6 Oct 2008

• REC opinion

  Further Information Favourable Opinion